AANP Blog Naturopathic Medicine
Advanced Search

Corporate Partners

Register Now

 
 

 




Home > 2013 Annual Conference > Breast Cancer in Clinical Practice

Breast Cancer in Clinical Practice

Presented by Drs. Tina Kaczor, ND, FABNO; Lise Alschuler, ND, FABNO; Timothy Birdsall, ND, FABNO; and Daniel Lander, ND, FABNO

This preconference day has been approved for total of 6 CE units with 2 pharmacy.

Breast Cancer in Clinical Practice - That’s the title of the OncANP sponsored AANP preconference day that will be held Tuesday, July 9th (the day before the official start of the AANP Conference). Our goal is to provide a solid foundation of knowledge for doctors not well versed in the details of naturopathic oncology so that they can help their patients. Initially our idea was to run a “nat onc 101” course covering the general basics. The longer we tried to figure out what information should be covered and what should be left out, the more complicated this idea became. We ultimately decided that it would be more beneficial and clinically practical to provide more detailed information on treating one specific cancer during the course of the day.

Click here to continue reading
 


   
July 9, 2013 Topic
8:30 am - 9:30 am Breast cancer overview (staging, receptor status, prognostic factors, conventional therapeutic overview) 1 CE Unit, presented by Timothy Birdsall, ND

Breast cancer is the most common cancer occurring in women, and the second most common cause of cancer-related mortality in women. Every year, nearly 250,000 new cases of breast cancer are diagnosed, and the chance of a woman having invasive breast cancer some time during her life is currently about 1 in 8. This presentation will review the basic of breast cancer diagnosis, staging, receptor status, and prognostic factors, and provide an overview of conventional treatment options, including surgery, chemotherapy and radiation therapy.
 
9:30 am - 10:30 am Managing a patient with breast cancer: labs, talking with med oncs, surgical aftercare, managing metastatic disease, when to refer/emergent conditions 1 CE Unit, presented Tina Kaczor, ND, FABNO, and Lise Alschuler, ND, FABNO

Breast cancer is the 2nd most common cancer in U.S. and the most common cancer diagnosed in women. The majority of women diagnosed with breast cancer utilize dietary supplements and other naturopathic therapies throughout the continuum of their care. The case management provided by the naturopathic doctor is of critical importance to the survival and well-being of the patient. This presentation will outline the guideposts of this naturopathic management. Specific discussion will include the use of biomarkers and hormonal analysis to establish the extent of disease as well as to identify contributory components of the bodily terrain. Additionally, strategies to facilitate communications and collaboration with conventional care providers throughout active treatment and post-treatment monitoring will be shared. Finally, the areas of surgical aftercare, identification of emergent conditions and management of metastatic disease will be highlighted.
 
10:30 am - 11:00 am Lymphedema Management 1 CE, presented by Julia Osbourne

1)   Gain deeper insight and understanding of the physiology of the lymphatic system during the soft tissue healing processes following surgery and/or radiation therapy
2)   Understand how the concept of “altered fluid dynamics” can impact the quality of soft tissue healing and joint mobility during the acute, intermediate, and long term phases of patient recovery irrespective of the onset of lymphedema
3)   Recognize “Axillary Web Syndrome”/“Cording” and understand the cause and effect factors related to the patient’s levels of activity, or non-activity, following surgery, and/or the initiation of chemotherapy, and/or the initiation of radiation therapy
4)   Understand advanced and pro-active ideas about lymphedema risk reduction, improving the endurance of the lymphatic system, lymphatic system thresholds, and patient empowerment to build an individualized exercise program, as well as their own vocation, and their own hobbies back into their lives without over-stressing their lymphatic systems
 
11:00 am Break
 
11:30 am - 12:30 pm Managing patients during radiation therapy, chemotherapy 1 CE Unit (.5 Rx), Daniel Lander, ND, FABNO

Providing naturopathic support for patients undergoing active chemotherapy or radiation therapy can often prevent or mitigate side effects and may help prevent delays in treatment or dose reductions, ultimately improving the efficacy of these therapies.  However, there is also a significant potential for negative interactions which could interfere with a patients conventional care and even decrease their chance at cure.  With such high stakes, navigating these waters can be overwhelming for the clinician.  During this lecture the most commonly used breast cancer chemotherapeutic regimens will be reviewed and the use of concurrent safe and effective evidence-based naturopathic support during active treatment will be discussed.
 
12:30 pm - 1:45 pm Lunch
 
1:45 pm - 2:45 pm Managing patients on targeted therapy - Tamoxifen, AIs, trastuzumab 1 CE Unit (1 Rx), Tina Kaczor, ND, FABNO

There are 2.9 million women with a history of breast cancer in the US. Many of these women are taking adjuvant drugs for years after their diagnosis. Selective Estrogen Receptor Modulators (SERMS), Aromatase Inhibitors (AI’s) and monoclonal antibodies (Mab’s) are used to lessen the risk of recurrence and/or treat known disease.  This presentation will review the drugs used, their risk reduction potential, and their side effects. Emphasis will be given to measures that can lessen the side effects and improve the woman’s quality of life.
 
2:45 pm - 3:45 pm Secondary prevention strategies (emphasis on lifestyle-based strategies, nutrients, botanicals) 1 CE Unit (.5 Rx), Lise Alschuler, ND, FABNO

This presentation will provide a comprehensive strategy for altering the course of breast cancer recurrence.  Based upon the principles of epigenetics, this presentation will explore the ways in which lifestyle, nutrition and targeted dietary supplements alter our state of inflammation, insulin resistance, stress, toxicity and immunity, and hormonal mileau - and in so doing create persistent influences on gene expression that favor or disfavor breast cancer development. Specific and clinically valid dietary interventions, dietary supplements, and lifestyle behaviors to modify these bodily influences for the breast cancer survivor will be discussed. Finally, the key opportunity created by the diagnosis of breast cancer for the achievement of deeply restorative health will conclude the presentation.
 
3:45 pm - 4:15 pm Break
 
4:15 pm - 4:45 pm Q & A with all speakers .5 CE Unit